These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30452972)

  • 1. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
    Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
    Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
    Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
    Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
    Agarwal C; Tyagi A; Kaur M; Agarwal R
    Carcinogenesis; 2007 Jul; 28(7):1463-70. PubMed ID: 17341659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.
    Wang YX; Cai H; Jiang G; Zhou TB; Wu H
    Asian Pac J Cancer Prev; 2014; 15(16):6791-8. PubMed ID: 25169527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
    Wu X; Yan Q; Zhang Z; Du G; Wan X
    Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells.
    Liu Y; Yu Q; Chen Y
    Biomed Pharmacother; 2018 Dec; 108():716-723. PubMed ID: 30248539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BF175 inhibits endometrial carcinoma through SREBP-regulated metabolic pathways in vitro.
    Wang Q; Hu R; Li W; Tai Y; Gu W; Das BC; Yang F; Ji J; Wang C; Zhou J
    Mol Cell Endocrinol; 2021 Mar; 523():111135. PubMed ID: 33359761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma.
    Makhmalzadeh BS; Molavi O; Vakili MR; Zhang HF; Solimani A; Abyaneh HS; Loebenberg R; Lai R; Lavasanifar A
    J Pharm Pharm Sci; 2018; 21(1):143-159. PubMed ID: 29789104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin promotes the apoptosis of gastric cancer BGC823 cells through caspase pathway.
    Li R; Yu J; Wang C
    J BUON; 2017; 22(5):1148-1153. PubMed ID: 29135096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
    Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway.
    Chen K; Zhao L; He H; Wan X; Wang F; Mo Z
    Int J Mol Med; 2014 Oct; 34(4):1073-80. PubMed ID: 25109869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells.
    Patel S; Waghela B; Shah K; Vaidya F; Mirza S; Patel S; Pathak C; Rawal R
    Sci Rep; 2018 Nov; 8(1):16985. PubMed ID: 30451890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT.
    Mao J; Yang H; Cui T; Pan P; Kabir N; Chen D; Ma J; Chen X; Chen Y; Yang Y
    Eur J Pharmacol; 2018 Aug; 832():39-49. PubMed ID: 29782854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
    World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
    Byun HJ; Darvin P; Kang DY; Sp N; Joung YH; Park JH; Kim SJ; Yang YM
    Oncol Rep; 2017 Jun; 37(6):3270-3278. PubMed ID: 28440514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma.
    Zhou Q; Kong D; Li W; Shi Z; Liu Y; Sun R; Ma X; Qiu C; Liu Z; Hou Y; Jiang J
    Life Sci; 2023 May; 320():121512. PubMed ID: 36858312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism.
    Yao L; Chen S; Li W
    Arch Biochem Biophys; 2020 May; 684():108327. PubMed ID: 32142890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvianolic acids improve liver lipid metabolism in ovariectomized rats via blocking STAT-3/SREBP1 signaling.
    Chen J; Yue J; Liu J; Liu Y; Jiao KL; Teng MY; Hu CY; Zhen J; Wu MX; Zhou M; Li Z; Li Y
    Chin J Nat Med; 2018 Nov; 16(11):838-845. PubMed ID: 30502765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.
    Zhuang Q; Hong F; Shen A; Zheng L; Zeng J; Lin W; Chen Y; Sferra TJ; Hong Z; Peng J
    Int J Oncol; 2012 May; 40(5):1569-74. PubMed ID: 22218594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell Lymphoma.
    Ortona E; Locatelli SL; Pagano MT; Ascione B; Careddu G; Dupuis ML; Marconi M; Carlo-Stella C; Malorni W; Matarrese P; Pierdominici M
    Anticancer Res; 2022 Feb; 42(2):767-779. PubMed ID: 35093875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.